A systematic, quantitative review of blood autoantibodies in schizophrenia

Amaka Ezeoke, Andrew Mellor, Peter Buckley, Brian Miller

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

Objective: Schizophrenia is associated with immune system dysfunction, including an increased prevalence of autoimmune disorders and autoantibodies. We performed a systematic, quantitative review of self-reacting blood antibodies in patients with schizophrenia. Method: We identified articles by searching PubMed, PsychInfo, and ISI, and the reference lists of identified studies. Results: Eighty-one of 111 studies identified met the inclusion criteria. There was a significant increased prevalence of positive titers for 20 different autoantibodies in patients with schizophrenia compared to controls. The prevalence of positive anti-cardiolipin IgG and NMDA receptor titers was also significantly increased in subjects with first-episode psychosis versus controls (p < 0.01). Absolute titers for anti-cardiolipin IgG and IgM, and nerve growth factor were significantly increased in patients with schizophrenia compared to controls (p < 0.02 for each). Conclusion: Schizophrenia is associated with an increased prevalence of multiple autoantibodies, although there is marked study heterogeneity, and correlations between autoantibodies and clinical features are inconsistent. This area merits more research evaluation, especially controlling for potential confounding factors such as clinical status, age, genetic background, psychotropic medications, BMI, and smoking.

Original languageEnglish (US)
Pages (from-to)245-251
Number of pages7
JournalSchizophrenia Research
Volume150
Issue number1
DOIs
StatePublished - Oct 1 2013

Fingerprint

Autoantibodies
Schizophrenia
Cardiolipins
IgG Receptors
Nerve Growth Factor
N-Methyl-D-Aspartate Receptors
PubMed
Psychotic Disorders
Immune System
Smoking
Antibodies
anti-IgG

Keywords

  • Autoantibody
  • Autoimmune
  • Epidemiology
  • First-episode psychosis
  • Immunology
  • Meta-analysis
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

A systematic, quantitative review of blood autoantibodies in schizophrenia. / Ezeoke, Amaka; Mellor, Andrew; Buckley, Peter; Miller, Brian.

In: Schizophrenia Research, Vol. 150, No. 1, 01.10.2013, p. 245-251.

Research output: Contribution to journalReview article

Ezeoke, Amaka ; Mellor, Andrew ; Buckley, Peter ; Miller, Brian. / A systematic, quantitative review of blood autoantibodies in schizophrenia. In: Schizophrenia Research. 2013 ; Vol. 150, No. 1. pp. 245-251.
@article{ceb612605f8345889368a5183dd24ac5,
title = "A systematic, quantitative review of blood autoantibodies in schizophrenia",
abstract = "Objective: Schizophrenia is associated with immune system dysfunction, including an increased prevalence of autoimmune disorders and autoantibodies. We performed a systematic, quantitative review of self-reacting blood antibodies in patients with schizophrenia. Method: We identified articles by searching PubMed, PsychInfo, and ISI, and the reference lists of identified studies. Results: Eighty-one of 111 studies identified met the inclusion criteria. There was a significant increased prevalence of positive titers for 20 different autoantibodies in patients with schizophrenia compared to controls. The prevalence of positive anti-cardiolipin IgG and NMDA receptor titers was also significantly increased in subjects with first-episode psychosis versus controls (p < 0.01). Absolute titers for anti-cardiolipin IgG and IgM, and nerve growth factor were significantly increased in patients with schizophrenia compared to controls (p < 0.02 for each). Conclusion: Schizophrenia is associated with an increased prevalence of multiple autoantibodies, although there is marked study heterogeneity, and correlations between autoantibodies and clinical features are inconsistent. This area merits more research evaluation, especially controlling for potential confounding factors such as clinical status, age, genetic background, psychotropic medications, BMI, and smoking.",
keywords = "Autoantibody, Autoimmune, Epidemiology, First-episode psychosis, Immunology, Meta-analysis, Schizophrenia",
author = "Amaka Ezeoke and Andrew Mellor and Peter Buckley and Brian Miller",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.schres.2013.07.029",
language = "English (US)",
volume = "150",
pages = "245--251",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - A systematic, quantitative review of blood autoantibodies in schizophrenia

AU - Ezeoke, Amaka

AU - Mellor, Andrew

AU - Buckley, Peter

AU - Miller, Brian

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Objective: Schizophrenia is associated with immune system dysfunction, including an increased prevalence of autoimmune disorders and autoantibodies. We performed a systematic, quantitative review of self-reacting blood antibodies in patients with schizophrenia. Method: We identified articles by searching PubMed, PsychInfo, and ISI, and the reference lists of identified studies. Results: Eighty-one of 111 studies identified met the inclusion criteria. There was a significant increased prevalence of positive titers for 20 different autoantibodies in patients with schizophrenia compared to controls. The prevalence of positive anti-cardiolipin IgG and NMDA receptor titers was also significantly increased in subjects with first-episode psychosis versus controls (p < 0.01). Absolute titers for anti-cardiolipin IgG and IgM, and nerve growth factor were significantly increased in patients with schizophrenia compared to controls (p < 0.02 for each). Conclusion: Schizophrenia is associated with an increased prevalence of multiple autoantibodies, although there is marked study heterogeneity, and correlations between autoantibodies and clinical features are inconsistent. This area merits more research evaluation, especially controlling for potential confounding factors such as clinical status, age, genetic background, psychotropic medications, BMI, and smoking.

AB - Objective: Schizophrenia is associated with immune system dysfunction, including an increased prevalence of autoimmune disorders and autoantibodies. We performed a systematic, quantitative review of self-reacting blood antibodies in patients with schizophrenia. Method: We identified articles by searching PubMed, PsychInfo, and ISI, and the reference lists of identified studies. Results: Eighty-one of 111 studies identified met the inclusion criteria. There was a significant increased prevalence of positive titers for 20 different autoantibodies in patients with schizophrenia compared to controls. The prevalence of positive anti-cardiolipin IgG and NMDA receptor titers was also significantly increased in subjects with first-episode psychosis versus controls (p < 0.01). Absolute titers for anti-cardiolipin IgG and IgM, and nerve growth factor were significantly increased in patients with schizophrenia compared to controls (p < 0.02 for each). Conclusion: Schizophrenia is associated with an increased prevalence of multiple autoantibodies, although there is marked study heterogeneity, and correlations between autoantibodies and clinical features are inconsistent. This area merits more research evaluation, especially controlling for potential confounding factors such as clinical status, age, genetic background, psychotropic medications, BMI, and smoking.

KW - Autoantibody

KW - Autoimmune

KW - Epidemiology

KW - First-episode psychosis

KW - Immunology

KW - Meta-analysis

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84884159215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884159215&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2013.07.029

DO - 10.1016/j.schres.2013.07.029

M3 - Review article

VL - 150

SP - 245

EP - 251

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1

ER -